Obstetricians' Views on the Reasons for Egypt's High Caesarean Section Rates
Sponsor
Minia University (Other)
Overall Status
Completed
CT.gov ID
NCT04898244
Collaborator
(none)
201
1
24
8.4
Study Details
Study Description
Brief Summary
Handling of questionnaires to a number of obstetricians from different hospitals to show their perceptions about causes of high cs rate in Egypt
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
An open-ended self-administered questionnaire Handled to a number of obstetricians from different hospitals to show their perceptions about causes of the high cs rate in Egypt.
Study Design
Study Type:
Observational [Patient Registry]
Actual Enrollment
:
201 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Causes of High Caesarean Section Rates in Egypt: Perception of Obstetricians
Actual Study Start Date
:
Aug 12, 2018
Actual Primary Completion Date
:
Aug 12, 2020
Actual Study Completion Date
:
Aug 12, 2020
Outcome Measures
Primary Outcome Measures
- Reasons of the High Caesarean Section Rates in Egypt. [12 months]
A questionnaire filled by Obstetricians working in Egypt to explore the reasons of high Caesarean Section Rates from their point of view.
Eligibility Criteria
Criteria
Ages Eligible for Study:
28 Years
to 40 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
Obstetricians from different hospitals. -
Exclusion Criteria:
Refusal to participate
-
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Minia university | Minya | Egypt |
Sponsors and Collaborators
- Minia University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Saad El Gelany,MD,
Professor,
Minia University
ClinicalTrials.gov Identifier:
NCT04898244
Other Study ID Numbers:
- MUEOB0022
First Posted:
May 24, 2021
Last Update Posted:
May 24, 2021
Last Verified:
May 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Saad El Gelany,MD,
Professor,
Minia University